NCT03106714View on ClinicalTrials.gov

Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil

CompletedOBSERVATIONAL
Enrollment

260

Participants

Timeline

Start Date

July 21, 2017

Primary Completion Date

June 26, 2020

Study Completion Date

June 26, 2020

Conditions
Zika Virus
Interventions
DIAGNOSTIC_TEST

RT-PCR

Persistence of detectable Zika virus (by RT-PCR test) in all selected body fluids

Trial Locations (3)

69040000

Tropical Medicine Foundation, Manaus

50670-420

Research Centre Aggeu Magalhães, Oswaldo Cruz Foundation, Recife

21040-360

Evandro Chagas National Institute of Infectious Diseases - Oswaldo Cruz Foundation, Rio de Janeiro

All Listed Sponsors
collaborator

World Health Organization

OTHER

collaborator

Ministry of Health, Brazil

OTHER_GOV

collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

collaborator

Wellcome Trust

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Oswaldo Cruz Foundation

OTHER

NCT03106714 - Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil | Biotech Hunter | Biotech Hunter